BIOUSIAN BIOSYSTEMS, INC. (BBI)

Company Information

Company Name
BIOUSIAN BIOSYSTEMS, INC. (BBI)
Address
51 FOLLEN RD
LEXINGTON, MA, 02421
Phone
n/a
URL
n/a
DUNS
809896025
Number of Employees
2
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$199,556.00
1
SBIR Phase II
$992,331.00
1

Award List

  1. Novel Glycosylated Delta Opioid Receptor Agonists for Chronic Inflammatory Pain

    Amount: $199,556.00

    DESCRIPTION (provided by applicant): Biousian Biosystems Inc. (BBI) intends to develop novel, glycosylated, deltorphin-based peptides as orally available drugs for the treatment of chronic inflammator ...

    SBIR Phase I 2009 Department of Health and Human Services
  2. Novel Glycosylated Delta Opioid Receptor Agonists for Chronic Inflammatory Pain

    Amount: $992,331.00

    DESCRIPTION (provided by applicant): Traditionally, Mu opioid receptor (MOR) agonists have not been given as first line treatments for neuropathic pain due to their significant adverse side effects. B ...

    SBIR Phase II 2011 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government